Ballentine Partners, LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1374889 Waltham, MA

Position in KRYS

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$794,629

+$248,284 QoQ

Shares Held

2,138

+1.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#10

of 36 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ballentine Partners, LLC holds $12,066,429 across 29 Biotechnology names. KRYS ranks #2 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,245	$2,605,347
2	KRYS	Krystal Biotech, Inc. This page	2,138	$794,629
3	ARGX	Argenx SE	772	$716,237
4	REGN	Regeneron Pharmaceuticals, Inc.	1,054	$657,210
5	INCY	Incyte Corp	4,816	$545,940
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,695	$510,244
7	RPRX	Royalty Pharma plc	9,027	$506,143
8	HALO	Halozyme Therapeutics, Inc.	6,331	$495,526

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$794,629	2,138	+1.1%	Shares	Other	2026-07-17
2026-03-31	$546,345	2,115	+0.3%	Shares	Other	2026-05-14
2025-12-31	$519,704	2,108	-0.3%	Shares	Sole	2026-02-03
2025-09-30	$373,359	2,115	0.0%	Shares	Other	2025-11-03
2025-06-30	$290,726	2,115	-1.0%	Shares	Other	2025-07-15
2025-03-31	$385,120	2,136	-0.4%	Shares	Other	2025-05-01
2024-12-31	$336,034	2,145	+2.7%	Shares	Other	2025-01-16
2024-09-30	$380,260	2,089	0.0%	Shares	Other	2024-10-23
2024-06-30	$383,623	2,089	+0.4%	Shares	Other	2024-08-06
2024-03-31	$370,093	2,080	0.0%	Shares	Other	2024-04-11
2023-12-31	$258,044	2,080	0.0%	Shares	Other	2024-01-23
2023-09-30	$241,280	2,080	0.0%	Shares	Other	2023-10-19
2023-06-30	$244,191	2,080	—	Shares	Other	2023-07-26
No filing history on record for this holder in this stock.